SARS-CoV-2 and HIV coinfection: clinical experience from Rhode Island, United States
SARS-CoV-2 and HIV coinfection: clinical experience from Rhode Island, United States
复制标题
DOI:
10.1002/jia2.25573
复制
发表时间:
2020-07-01
影响因子:
6
通讯作者:
Kantor, Rami
中科院分区:
文献类型:
--
作者:
Byrd, Katrina M.;Beckwith, Curt G.;Kantor, Rami
Introduction Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has infected >6 million people worldwide since December 2019. Global reports of HIV/SARS-CoV-2 coinfection are limited. To better understand the impact of the coronavirus disease 2019 (COVID-19) pandemic on persons with HIV and improve their care, we present an outpatient and inpatient clinical experience of HIV/SARS-CoV-2 coinfection from Rhode Island, US. Methods We describe outpatient and inpatient preparedness for the COVID-19 pandemic, and present a case series of all known patients with HIV/SARS-CoV-2 coinfection at The Miriam Hospital and Rhode Island Hospital, and The Miriam Hospital Infectious Diseases and Immunology Center, in Providence, Rhode Island, US. Results and discussion The Infectious Diseases and Immunology Center rapidly prepared for outpatient and inpatient care of persons with HIV and SARS-CoV-2. Between 30 March and 20 May 2020, 27 patients with HIV were diagnosed with SARS-CoV-2. Twenty were male, six female and one transgender female; average age was 49 years; 13/27 were Hispanic and 6/27 were African American. All had HIV viral load